Berberine

Berberine is a yellow isoquinoline alkaloid found in several plants including Berberis vulgaris (barberry), goldenseal, goldthread, and Oregon grape. It has been used in traditional Chinese and Ayurvedic medicine for millennia — primarily for its antimicrobial and glucose-regulating properties. In the context of modern longevity science, berberine's significance lies in its pharmacological similarity to metformin: it activates AMP-activated protein kinase (AMPK) through inhibition of mitochondrial Complex I, producing a nearly identical downstream cascade. This mechanism — dubbed 'nature's metformin' by researchers and popularized in longevity circles since a 2021 analysis in Ageing Research Reviews — produces the same core effects: inhibition of mTOR signaling, reduction of IGF-1, enhanced autophagy, improved insulin sensitivity, reduced gluconeogenesis, and lower circulating glucose and lipid levels. A 2008 RCT found berberine matched metformin's glycemic control in type 2 diabetes patients at 1500mg/day — a comparison that entered the popular consciousness as evidence of bioequivalence. Whether that equivalence extends to metformin's broader geroprotective effects remains an active research question. Berberine offers two significant advantages over metformin for the biohacker context: OTC availability (no prescription required in most jurisdictions) and substantially more accessible pricing. Quality berberine HCl supplementation at 500mg three times daily costs approximately $20–40/month. Dihydroberberine (DHB), a reduced form with higher oral bioavailability and fewer GI side effects, is also available OTC at somewhat higher cost. Limitations worth acknowledging: berberine's human longevity data lags behind metformin by decades, there is no TAME-equivalent trial, and its bioavailability from standard HCl salt formulations is poor (~5%) due to first-pass metabolism and efflux transport. Taking berberine with a meal containing fat and cycling its use (two weeks on, one week off) are common strategies to maintain sensitivity. Interactions with CYP3A4-metabolized medications require attention.